# OrganHeal AI — Engineering Master

> Version: 1.0
>
> Status: Active
>
> Current Primary Phase: Gate 3 — Intelligence Maturation
>
> Purpose: Single source of truth for OrganHeal engineering maturity,
> production-readiness evidence, release gates, operational risks, and
> engineering priorities.

---

# 1. Engineering Governance

OrganHeal is evolving into a Personal Health Intelligence Platform combining
clinical value, AI, engineering quality, security, reliability, privacy, and
scalability.

Engineering maturity is evidence-based. A capability is considered verified
only when implementation, automated testing, or production behavior has been
checked directly.

Scores and benchmarks in this document represent observed engineering maturity
and measured behavior. They do not represent guaranteed maximum production
capacity or a zero-error guarantee.

---

# 2. Current Engineering Scorecard

| Area | Current | Target | Status |
|---|---:|---:|---|
| Product Vision | 9.5 | 10 | Strong |
| UI / UX | 9.3 | 10 | Strong |
| Architecture | 9.1 | 10 | Strong |
| Documentation | 9.1 | 10 | Strong |
| Performance | 8.4 | 9.5 | Improving |
| Database Design | 9.0 | 9.5 | Strong |
| Security | 9.2 | 9.5 | Strong |
| AI Intelligence | 6.8 | 10 | Developing |
| Background Processing | 9.1 | 10 | Strong |
| Monitoring & Logging | 9.0 | 10 | Strong |
| Automated Testing | 9.1 | 10 | Strong |
| Load Testing | 7.3 | 10 | In Progress |
| Production Readiness | 9.3 | 10 | Gate 2 Passed |

---

# 3. Current Phase

## Gate 3 — Intelligence Maturation

Gate 2 Status: **Passed with Monitored Operational Risks**

Gate 3 Status: **Active**

### Phase 17 — Intelligence Architecture and Integration Audit

Status: **Completed**

The Gate 3 architecture audit verified that OrganHeal already contains a
substantial and connected intelligence foundation. The audit therefore did not
introduce another parallel intelligence engine or unnecessary runtime.

Verified architecture includes:

- Foundational Health Intelligence built from the patient summary
- Unified Health Runtime orchestration
- Health Intelligence Runtime module composition
- Evidence Intelligence
- Clinical Confidence
- Health Momentum
- Next Decision
- Decision Impact
- Health Intelligence Summary
- Clinical evidence sufficiency
- Clinical evidence weighting
- Clinical hypothesis generation
- Clinical hypothesis ranking
- Clinical conflict resolution
- Clinical confidence calibration
- Clinical Decision Trace
- Clarification selection
- Clinical reasoning state and reasoning loop
- Clinical narrative generation
- Clinical response composition
- Assistant clinical-urgency handling
- Assistant orchestration
- Report-grounded response prioritization
- Arabic and English assistant behavior
- Unified primary-action propagation across intelligence, Health Plan, and
  assistant-facing context

The audit also confirmed that `ClinicalDecisionResult` and `NextDecision`
represent different architectural responsibilities rather than duplicate
decision engines.

`ClinicalDecisionResult` provides Health Intelligence, Health Passport,
Health Timeline, personalized knowledge, and pipeline metadata.

`NextDecision` is a Health Intelligence Runtime module responsible for the
user's next actionable product and follow-up decision.

No architecture refactor is currently justified solely to merge these two
responsibilities.

The audit also verified that the Assistant path connects clinical urgency,
clinical reasoning, hypothesis ranking, conflict resolution, confidence
calibration, Decision Trace, clarification, clinical narrative, and response
composition before selecting the final response.

Phase 17 is therefore complete.

Gate 3 remains active because the next objective is not further architecture
discovery. The next objective is measurable Intelligence Maturation:
improving reasoning quality, personalization, longitudinal understanding,
clinical usefulness, and decision quality while preserving the architecture
and safety boundaries verified during Phase 17.

Gate 2 monitored operational risks remain active during Gate 3. Gate 2 closure
does not represent a zero-error or maximum-capacity claim.

---

# 4. Gate 2 — Final Decision

## Status

**Passed with Monitored Operational Risks**

## Verified Gate 2 Areas

- Query and performance discipline
- Production database indexing
- Durable background-job architecture
- Background-job retry and final-failure handling
- Stale-job recovery
- Background-job idempotency controls
- Controlled background-job concurrency correctness
- API authentication and authorization hardening
- Private medical-report storage
- User-scoped storage isolation
- Upload restrictions
- WhatsApp webhook verification and request tracing
- Structured API logging
- Request IDs
- Health and queue monitoring
- Production Sentry error tracking
- Hosted production telemetry
- Automated regression testing
- Production dependency security audit
- Final application-level security review
- Baseline load testing
- Representative authenticated API performance baseline
- Production build verification

## Gate 2 Decision

The verified evidence is sufficient to close the Production Readiness
engineering gate and allow Gate 3 to become the primary development phase.

Gate 2 closure does not authorize claims of:

- zero production errors
- unlimited scalability
- maximum user capacity
- maximum database throughput
- maximum background-job throughput

Operational risks identified during Gate 2 remain active and must continue to
be monitored during Gate 3 and reconsidered before Gate 4 launch approval.

---

# 5. Automated Testing

Latest verified full regression run:

- Test files: 74 passed
- Tests: 456 passed
- Failed tests: 0
- TypeScript verification passed
- Production build verification passed
- `git diff --check` passed

Standard engineering verification:

```text
npx tsc --noEmit
npm test
npm run build
npm audit --omit=dev
git diff --check